Healthcare and research organizations across North America are increasingly utilizing clinical databases, genomic information, and computational platforms for repurposing research. Data-driven approaches can improve the identification of promising drug candidates. Continued digital transformation is supporting the growth of technology-enabled repurposing programs. The Drug Repurposing Market...